| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ADMA | Common Stock | Options Exercise | $216K | +64.4K | +3.13% | $3.35 | 2.12M | Aug 26, 2024 | Direct | |
| transaction | ADMA | Common Stock | Options Exercise | $275K | +55K | +2.59% | $5.00 | 2.18M | Aug 26, 2024 | Direct | |
| transaction | ADMA | Common Stock | Options Exercise | $101K | +17K | +0.78% | $5.96 | 2.2M | Aug 26, 2024 | Direct | |
| transaction | ADMA | Common Stock | Options Exercise | $379K | +40.5K | +1.84% | $9.37 | 2.24M | Aug 26, 2024 | Direct | |
| transaction | ADMA | Common Stock | Options Exercise | $648K | +60K | +2.68% | $10.80 | 2.3M | Aug 26, 2024 | Direct | |
| transaction | ADMA | Common Stock | Sale | -$4.19M | -237K | -10.31% | $17.69 | 2.06M | Aug 26, 2024 | Direct | F1 |
| transaction | ADMA | Common Stock | Options Exercise | $1.15M | +342K | +16.6% | $3.35 | 2.4M | Aug 27, 2024 | Direct | |
| transaction | ADMA | Common Stock | Options Exercise | $138K | +47.4K | +1.97% | $2.92 | 2.45M | Aug 27, 2024 | Direct | |
| transaction | ADMA | Common Stock | Sale | -$6.73M | -389K | -15.9% | $17.29 | 2.06M | Aug 27, 2024 | Direct | F2, F3, F4, F5 |
| holding | ADMA | Common Stock | 1.14M | Aug 26, 2024 | See Footnote | F6 | |||||
| holding | ADMA | Common Stock | 581K | Aug 26, 2024 | See Footnote | F7 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ADMA | Common Stock | Options Exercise | -$216K | -64.4K | -5.61% | $3.35 | 1.08M | Aug 26, 2024 | Common Stock | 64.4K | $3.35 | Direct | F8 |
| transaction | ADMA | Common Stock | Options Exercise | -$275K | -55K | -100% | $5.00 | 0 | Aug 26, 2024 | Common Stock | 55K | $5.00 | Direct | F9 |
| transaction | ADMA | Common Stock | Options Exercise | -$101K | -17K | -100% | $5.96 | 0 | Aug 26, 2024 | Common Stock | 17K | $5.96 | Direct | F10, F14 |
| transaction | ADMA | Common Stock | Options Exercise | -$379K | -40.5K | -100% | $9.37 | 0 | Aug 26, 2024 | Common Stock | 40.5K | $9.37 | Direct | F11, F14 |
| transaction | ADMA | Common Stock | Options Exercise | -$648K | -60K | -100% | $10.80 | 0 | Aug 26, 2024 | Common Stock | 60K | $10.80 | Direct | F12, F14 |
| transaction | ADMA | Common Stock | Options Exercise | -$1.15M | -342K | -31.58% | $3.35 | 741K | Aug 27, 2024 | Common Stock | 342K | $3.35 | Direct | F8 |
| transaction | ADMA | Common Stock | Options Exercise | -$138K | -47.4K | -100% | $2.92 | 0 | Aug 27, 2024 | Common Stock | 47.4K | $2.92 | Direct | F13 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $17.50 to $18.45. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F2 | The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $17.25 to $17.375. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F3 | Includes, as of the transaction date, (i) 557,728 restricted stock units ("RSUs") granted on February 26, 2024, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 430,272 unvested RSUs granted on March 6, 2023 that will vest quarterly on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (iii) 150,000 unvested RSUs granted on March 7, 2022 that will vest quarterly on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; |
| F4 | (continued from footnote 3) (iv) 113,438 unvested time-based RSUs granted on September 29, 2021, subject to time-based vesting conditions which will vest in eight (8) equal quarterly installments over a period of two years following December 31, 2022, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date; (v) 45,788 unvested RSUs granted on February 25, 2021, which will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting; |
| F5 | (continued from footnote 4) and (vi) 762,500 shares of common stock owned by the reporting person, which reflects prior purchases and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes. |
| F6 | These shares are owned by Areth, LLC ("Areth"). The reporting person is a control person of Areth. |
| F7 | These shares are owned by Hariden, LLC ("Hariden"). The reporting person is the managing member of Hariden. |
| F8 | These options were granted on March 6, 2023 and vest over four years with 25% of the shares of common stock underlying the options vesting on the one year anniversary of the date of grant and the remaining 75% of such shares vesting monthly in equal installments over the next three years, becoming fully vested on March 6, 2027. |
| F9 | These options were granted on February 14, 2017 and vested over four years with 25% of the shares of common stock underlying the option vesting on the one year anniversary of the grant date and the remaining 75% of the shares of common stock underlying the option vesting in equal monthly installments thereafter beginning on March 14, 2018, becoming fully vested on February 14, 2021. |
| F10 | These options were granted on January 28, 2016 and vested over four years with 25% vesting on the one year anniversary of the date of grant and the remaining 75% vesting monthly in equal installments over the next three years thereafter, becoming fully vested on January 28, 2020. |
| F11 | These options were granted on October 9, 2015 and vested over four years with 25% vesting on the one year anniversary of the date of grant and the remaining 75% vesting monthly in equal installments over the next three years thereafter, becoming fully vested on October 9, 2019. |
| F12 | These options were granted on January 30, 2015 and vested over four years with 25% vesting on the one year anniversary of the date of grant and the remaining 75% vesting monthly in equal installments over the next three years thereafter, becoming fully vested on January 30, 2019. |
| F13 | These options were granted on February 28, 2020 and vested over four years with 25% of the shares of common stock underlying the options vesting on the one year anniversary of the date of grant and the remaining 75% of such shares vesting monthly in equal installments over the next three years, becoming fully vested on February 28, 2024. |
| F14 | The Reporting Person is exercising these options due, in part, to their near-term expiration date. |